News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
693,639 Results
Type
Article (39431)
Company Profile (249)
Press Release (653959)
Section
Business (204048)
Career Advice (2006)
Deals (35408)
Drug Delivery (93)
Drug Development (80968)
Employer Resources (169)
FDA (16139)
Job Trends (14832)
News (344926)
Policy (32479)
Tag
2024 BioCapital Digital (6)
2024 BioForest Digital (1)
2024 BioForest Standard (1)
2024 BioMidwest Digital (7)
2024 BioMidwest Standard (1)
2024 Bio NC Digital (4)
2024 Bio NC Standard (2)
2024 Biotech Bay Standard (17)
2024 Biotech Beach Digital (8)
2024 Biotech Beach Standard (4)
2024 Genetown Digital (5)
2024 Genetown Standard (9)
2024 Lone Star Bio Digital (4)
2024 Pharm Country Digital (5)
2024 Pharm Country Standard (5)
2025 BioForest Digital (1)
2025 Lone Star Bio Digital (5)
2026 BioCapital Standard (1)
2026 BioMidwest Elite (1)
2026 Biotech Beach Elite (1)
2026 Genetown Elite (2)
2026 Pharm Country Standard (1)
Academia (2538)
Accelerated approval (2)
Adcomms (20)
Allergies (77)
Alliances (49331)
ALS (74)
Alzheimer's disease (1323)
Antibody-drug conjugate (ADC) (98)
Approvals (16126)
Artificial intelligence (209)
Autoimmune disease (10)
Automation (14)
Bankruptcy (357)
Best Places to Work (11637)
BIOSECURE Act (18)
Biosimilars (92)
Biotechnology (177)
Bladder cancer (50)
Brain cancer (23)
Breast cancer (231)
Cancer (1781)
Cardiovascular disease (132)
Career advice (1670)
Career pathing (28)
CAR-T (130)
Cell therapy (372)
Cervical cancer (13)
Clinical research (65371)
Collaboration (694)
Compensation (383)
Complete response letters (18)
COVID-19 (2568)
CRISPR (31)
C-suite (174)
Cystic fibrosis (97)
Data (1703)
Decentralized trials (2)
Denatured (14)
Depression (35)
Diabetes (222)
Diagnostics (6300)
Digital health (17)
Diversity (8)
Diversity, equity & inclusion (44)
Drug discovery (102)
Drug pricing (93)
Drug shortages (23)
Duchenne muscular dystrophy (62)
Earnings (85692)
Editorial (27)
Employer branding (21)
Employer resources (145)
Events (111155)
Executive appointments (586)
FDA (17096)
Featured Employer (50)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (6)
Funding (625)
Gene editing (84)
Generative AI (18)
Gene therapy (255)
GLP-1 (658)
Government (4363)
Grass and pollen (4)
Guidances (44)
Healthcare (18785)
Huntington's disease (22)
IgA nephropathy (19)
Immunology and inflammation (88)
Indications (23)
Infectious disease (2686)
Inflammatory bowel disease (124)
Inflation Reduction Act (8)
Influenza (43)
Intellectual property (69)
Interviews (311)
IPO (16468)
IRA (39)
Job creations (3627)
Job search strategy (1421)
Kidney cancer (9)
Labor market (26)
Layoffs (441)
Leadership (14)
Legal (7890)
Liver cancer (68)
Lung cancer (259)
Lymphoma (119)
Machine learning (2)
Management (57)
Manufacturing (243)
MASH (57)
Medical device (13281)
Medtech (13286)
Mergers & acquisitions (19338)
Metabolic disorders (575)
Multiple sclerosis (58)
NASH (16)
Neurodegenerative disease (68)
Neuropsychiatric disorders (23)
Neuroscience (1747)
NextGen: Class of 2025 (6510)
Non-profit (4476)
Northern California (2203)
Now hiring (35)
Obesity (316)
Opinion (196)
Ovarian cancer (61)
Pain (68)
Pancreatic cancer (68)
Parkinson's disease (117)
Partnered (17)
Patents (176)
Patient recruitment (79)
Peanut (45)
People (56900)
Pharmaceutical (63)
Pharmacy benefit managers (18)
Phase I (20356)
Phase II (28793)
Phase III (21442)
Pipeline (799)
Podcasts (39)
Policy (97)
Postmarket research (2563)
Preclinical (8590)
Press Release (64)
Prostate cancer (84)
Psychedelics (30)
Radiopharmaceuticals (242)
Rare diseases (332)
Real estate (5897)
Recruiting (64)
Regulatory (21985)
Reports (43)
Research institute (2314)
Resumes & cover letters (349)
Rett syndrome (2)
RNA editing (1)
RSV (36)
Schizophrenia (58)
Series A (113)
Series B (68)
Service/supplier (11)
Sickle cell disease (49)
Southern California (1881)
Special edition (13)
Sponsored (28)
Startups (3569)
State (2)
Stomach cancer (11)
Supply chain (55)
The Weekly (24)
United States (19292)
Vaccines (622)
Venture capitalists (34)
Webinars (12)
Weight loss (214)
Women's health (30)
Worklife (13)
Date
Today (199)
Last 7 days (803)
Last 30 days (2886)
Last 365 days (34362)
2025 (5534)
2024 (35219)
2023 (40077)
2022 (51173)
2021 (55711)
2020 (54083)
2019 (46538)
2018 (35018)
2017 (32109)
2016 (31480)
2015 (37552)
2014 (31318)
2013 (26345)
2012 (28570)
2011 (29263)
2010 (27328)
Location
Africa (717)
Alabama (48)
Alaska (7)
Arizona (211)
Arkansas (12)
Asia (37555)
Australia (6140)
California (5007)
Canada (1757)
China (413)
Colorado (229)
Connecticut (238)
Delaware (110)
Europe (80511)
Florida (739)
Georgia (172)
Idaho (57)
Illinois (464)
India (20)
Indiana (272)
Iowa (7)
Japan (126)
Kansas (99)
Kentucky (23)
Louisiana (7)
Maine (59)
Maryland (765)
Massachusetts (3803)
Michigan (201)
Minnesota (345)
Mississippi (2)
Missouri (70)
Montana (27)
Nebraska (25)
Nevada (54)
New Hampshire (61)
New Jersey (1413)
New Mexico (27)
New York (1429)
North Carolina (861)
North Dakota (7)
Northern California (2203)
Ohio (176)
Oklahoma (13)
Oregon (32)
Pennsylvania (1137)
Puerto Rico (6)
Rhode Island (23)
South America (1093)
South Carolina (13)
South Dakota (1)
Southern California (1881)
Tennessee (83)
Texas (730)
Utah (155)
Virginia (116)
Washington D.C. (54)
Washington State (478)
West Virginia (3)
Wisconsin (44)
693,639 Results for "annovis inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Annovis Bio, Inc. Announces Closing of $21 Million Public Offering
February 5, 2025
·
3 min read
Press Releases
Annovis Bio, Inc. Announces Pricing of $21 Million Public Offering
February 4, 2025
·
3 min read
Pharm Country
Annovis Bio Inc. (NYSE: ANVS) Schedules Investor Webcast
Annovis Bio Inc. today announced that it will host an investor webcast to discuss recent developments and future plans for its lead drug candidate, Buntanetap.
June 5, 2024
·
2 min read
Pharm Country
Annovis Bio Inc. (NYSE: ANVS) Schedules Investor Webcast to Discuss Parkinson’s Disease Data
Annovis Bio Inc. today announced that it will host an investor webcast to discuss recent developments and future plans for its lead drug candidate, Buntanetap.
June 25, 2024
·
2 min read
Press Releases
Annovis to Present at Oppenheimer’s 35th Annual Healthcare Life Sciences Conference
February 7, 2025
·
2 min read
Pharm Country
Annovis Bio Files Provisional Patent for New Manufacturing Process of Crystalline Form of Buntanetap
Annovis Bio Inc. announced the filing of a provisional patent covering the manufacturing process of new solid forms of buntanetap.
June 27, 2024
·
3 min read
Business
Annovis Bio CEO Maria Maccecchini Issues Letter to Stockholders
Annovis Bio, Inc. announced that Maria Maccecchini, Founder, President, and CEO of Annovis, issued a letter to stockholders providing a review of Phase II/III data from its Alzheimer’s study and sharing next steps.
May 6, 2024
·
4 min read
Pharm Country
Annovis Bio Files Patent for New Composition of Matter for Buntanetap
Annovis Bio Inc announces the filing of the new composition of matter patent with the U.S. Patent and Trademark Office covering novel solid forms of buntanetap, selecting the best crystal, and building upon the provisional patent filed in June 2023.
June 26, 2024
·
3 min read
Press Releases
Annovis Announces First Patients Entered into Pivotal Phase 3 Study of Buntanetap for Early Alzheimer’s Disease
February 5, 2025
·
4 min read
Pharm Country
Annovis Announces New Publication in a Peer-Reviewed Journal
Annovis Bio, Inc. announced the publication of a new article focused on the comparison of pharmacokinetic profiles of Posiphen across different species in a peer-reviewed journal Biomolecules as part of the Special Issue: Role of Amyloid Protein in Neurological Diseases.
May 21, 2024
·
3 min read
1 of 69,364
Next
